As individuals with respiratory complications may fear visiting hospitals and/or clinics during lockdowns due to possible contact with SARS-CoV-2 and subsequent exacerbation of their current health conditions, ministries of health in lower- and middle-income countries have reported decreased TB testing. However, once nations ease lockdowns, numerous patients with more advanced stages of TB, both patients with delayed diagnosis and patients with interrupted treatment, will seek care after months of deferring medical consultations. Hence, the Stop TB Partnership estimates that a three-month lockdown and ten-month period of recovery would result in an additional 6.33 million cases of TB and additional 1.37 million deaths from TB globally between 2020 and 2025. In high-burden settings, deaths attributable to TB over 5 years could increase by up to 20%.